A prospective study of septicaemia on a paediatric oncology unit: a three-year experience at The Royal Liverpool Children's Hospital, Alder Hey, UK

Eur J Cancer. 2005 Sep;41(14):2132-40. doi: 10.1016/j.ejca.2005.04.037.

Abstract

Septicaemia in neutropaenic patients is predominantly due to gut translocation [endogenous septicaemia] and contamination of the central venous catheter by microorganisms not carried by the patient [exogenous septicaemia]. To control both types of infection, a protocol was implemented based on pre 1990's parenteral and enteral antimicrobials together with strict hygiene. Surveillance cultures of throat/rectum were taken to distinguish exogenous from endogenous septicaemia and enteral non-absorbable antibiotics are administered as part of selective decontamination of the digestive tract (SDD). This protocol was evaluated in a 14-bedded paediatric oncology unit over a period of 3 years. 313 Septicaemia episodes were recorded in 131 children. 28.4% of the septicaemias were caused by microorganisms associated with the unit, equivalent to 0.82 episodes per 100 patient days. Low-level pathogens such as coagulase-negative staphylococci caused more than 70% of infections. Amongst the potential pathogens, Pseudomonas species (7.8%) and Staphylococcus aureus (5.5%) were predominant. Antibiotic resistance was rare with no superinfections or outbreaks. Four patients (3%) died, two due to Candida species and two due to Pseudomonas aeruginosa. We believe that the addition of enteral non-absorbable antibiotics to systemic antibiotics maintained a low level of resistance and mortality but a randomised controlled trial is indicated to confirm these observations.

MeSH terms

  • Adolescent
  • Anti-Bacterial Agents / therapeutic use*
  • Antineoplastic Agents / adverse effects
  • Child
  • Child, Preschool
  • Cross Infection / prevention & control*
  • Drug Resistance
  • England
  • Female
  • Hospitals, Pediatric
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Infection Control / methods*
  • Male
  • Neoplasms / complications
  • Neoplasms / drug therapy*
  • Prospective Studies
  • Sepsis / microbiology
  • Sepsis / prevention & control*

Substances

  • Anti-Bacterial Agents
  • Antineoplastic Agents
  • Immunosuppressive Agents